Patch testing and diagnosis when suspecting allergic contact dermatitis from medical devices
- 1 July 2020
- journal article
- letter
- Published by Wiley in Contact Dermatitis
- Vol. 83 (4) , 333-335
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: Irritant contact dermatitis or allergic contact dermatitis?Contact Dermatitis, 2020
- Prevalence of contact dermatitis to glucose sensors in pediatric population and the main allergens involvedContact Dermatitis, 2020
- New positive patch test reactions on day 7—The additional value of the day 7 patch test readingContact Dermatitis, 2019
- N,N‐dimethylacrylamide—A new sensitizer in the FreeStyle Libre glucose sensorContact Dermatitis, 2019
- Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensorContact Dermatitis, 2017
- European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practiceContact Dermatitis, 2015
- Two decades of occupational (meth)acrylate patch test results and focus on isobornyl acrylateContact Dermatitis, 2013
- Screening for acrylate/methacrylate allergy in the baseline series: our experience in Sweden and SingaporeContact Dermatitis, 2008
- The development and course of patch‐test reactions to 2‐hydroxyethyl methacrylate and ethyleneglycol dimethacrylateContact Dermatitis, 2005
- Delayed patch test reactions at days 7 and 9Contact Dermatitis, 1989